FDA Inspection 1159955 — Aerie Pharmaceuticals Ireland Limited

Aerie Pharmaceuticals Ireland Limited — FEI 3015292277

The FDA completed an inspection of Aerie Pharmaceuticals Ireland Limited on July 29, 2021 in Athlone. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 29, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Athlone (Ireland)

Additional Details

Mutual Recognition Agreement (MRA)